Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2026Journal of Umm Al-Qura University for Medical SciencesOpen Access

Potentials of novel sepsis diagnostic biomarker in intensive care unit: Systematic review

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMohamed Mahmoud Nour Eldein

Discussion

Loading...

Member takes

Overview

Systematic review assesses the effectiveness of novel biomarkers for sepsis diagnosis in ICU, suggesting improvements in patient outcomes.

Key Points

  • The goal is to evaluate the clinical usefulness of novel biomarkers for diagnosing sepsis in ICU patients.
  • Employed a systematic review approach using multiple medical databases.
  • Focused on studies concerning novel diagnostic biomarkers for sepsis.
  • Summarized findings on the effectiveness of various biomarkers.
  • Identified recommended practices for the use of these biomarkers.
  • Highlighted several novel biomarkers including presepsin and CD64.
  • Observed limitations in distinguishing between infected and non-infected patients.
  • Emphasized the need for further testing of prospective biomarkers before clinical adoption.

Cite This Study

Mohamed Mahmoud Nour Eldein (2026) studied this question.

synapsesocial.com/papers/69d8962d6c1944d70ce07697https://doi.org/10.1007/s44361-025-00014-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Beyond Lactate: The Evolving Landscape of Biomarkers for Sepsis in Critical Care – A Systematic Review and Critical Analysis2025
  2. 2Unveiling promising sepsis biomarkers: a clinical perspective2024 · 1 citations
  3. 3Sepsis Biomarkers: What Surgeons Need to Know2025 · 2 citations
  4. 4Biomarkers in sepsis: the present and the future2024
  5. 5The search for biomarkers in the critically ill: a cautionary tale2018 · 2 citations